185 related articles for article (PubMed ID: 16111529)
1. Richter's syndrome--the downside of fludarabine?
Hamblin TJ
Leuk Res; 2005 Oct; 29(10):1103-4. PubMed ID: 16111529
[No Abstract] [Full Text] [Related]
2. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
3. Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
Chaker L; Segeren CM; Bot FJ; Maartense E
Eur J Haematol; 2010 Jul; 85(1):91-2. PubMed ID: 20331737
[No Abstract] [Full Text] [Related]
4. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
6. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.
Thornton PD; Bellas C; Santon A; Shah G; Pocock C; Wotherspoon AC; Matutes E; Catovsky D
Leuk Res; 2005 Apr; 29(4):389-95. PubMed ID: 15725472
[TBL] [Abstract][Full Text] [Related]
7. Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.
Bernasconi P; Paulli M; Orlandi E; Perfetti V; Giardini I; Zibellini S; Vanelli L; Tenore AM; Algarotti A; Boni M; De Amici M; Brusamolino E; Lazzarino M
Ann Hematol; 2007 Aug; 86(8):619-22. PubMed ID: 17356849
[No Abstract] [Full Text] [Related]
8. Fludarabine approved for use in chronic lymphocytic leukemia.
Oncology (Williston Park); 1991 Jun; 5(6):20. PubMed ID: 1831638
[No Abstract] [Full Text] [Related]
9. Fludarabine for chronic lymphocytic leukemia.
Erman M; Celik I; Tekuzman G
N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
Rath J; Geisler C; Christiansen CB; Hastrup N; Madsen HO; Andersen MK; Pedersen LB; Jurlander J
Haematologica; 2008 Sep; 93(9):1424-6. PubMed ID: 18641020
[No Abstract] [Full Text] [Related]
11. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
12. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
[No Abstract] [Full Text] [Related]
13. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine.
Med Lett Drugs Ther; 1991 Sep; 33(853):89-90. PubMed ID: 1886506
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus infection in Richter's transformation.
Ansell SM; Li CY; Lloyd RV; Phyliky RL
Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
[TBL] [Abstract][Full Text] [Related]
16. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
17. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
18. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Tsimberidou AM; Wierda WG; Plunkett W; Kurzrock R; O'Brien S; Wen S; Ferrajoli A; Ravandi-Kashani F; Garcia-Manero G; Estrov Z; Kipps TJ; Brown JR; Fiorentino A; Lerner S; Kantarjian HM; Keating MJ
J Clin Oncol; 2008 Jan; 26(2):196-203. PubMed ID: 18182662
[TBL] [Abstract][Full Text] [Related]
19. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
Saven A; Lemon RH; Piro LD
N Engl J Med; 1993 Mar; 328(11):812-3. PubMed ID: 8094889
[No Abstract] [Full Text] [Related]
20. Fludarabine for chronic lymphocytic leukemia.
Marchetti M; Barosi G; Liberato LN
N Engl J Med; 2001 Apr; 344(15):1166-7; author reply 1167-8. PubMed ID: 11302140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
